Palisade Bio Free Cash Flow (FCF) History (PALI)
Palisade Bio reported −$12.2M in free cash flow for fiscal 2024, a decrease of $1.1M from the previous fiscal year.
View full Palisade Bio company overviewPalisade Bio free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$12.2M | −$1.1M | — | — |
| 2023 | 2023-12-31 | −$11.1M | $2.2M | — | −4454.80% |
| 2022 | 2022-12-31 | −$13.4M | $1.4M | — | — |
| 2021 | 2021-12-31 | −$14.8M | −$10.0M | — | — |
| 2020 | 2020-12-31 | −$4.8M | $2.9M | — | −35310.65% |
| 2018 | 2018-12-31 | −$7.7M | $5.7M | — | −2959.28% |
| 2017 | 2017-12-31 | −$13.4M | $2.3M | — | −5164.45% |
| 2016 | 2016-12-31 | −$15.7M | $3.4M | — | −96726.55% |
| 2015 | 2015-12-31 | −$19.1M | −$7.2M | — | −183430.34% |
| 2014 | 2014-12-31 | −$11.9M | −$1.2M | — | −63264.38% |
| 2013 | 2013-12-31 | −$10.7M | −$2.2M | — | −9742.71% |
| 2012 | 2012-12-31 | −$8.5M | −$223,812 | — | −2088.98% |
| 2011 | 2011-12-31 | −$8.3M | $1.8M | — | −2123.04% |
| 2010 | 2010-12-31 | −$10.1M | −$4.8M | — | −1371.29% |
| 2009 | 2009-12-31 | −$5.2M | — | — | — |
Palisade Bio quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$3.1M | −$2.3M | — | — |
| Q3 2023 | 2023-09-30 | −$2.7M | $662,171 | — | — |
| Q3 2022 | 2022-09-30 | −$3.0M | $1.0M | — | — |
| Q3 2021 | 2021-09-30 | −$2.7M | $1.7M | — | — |
| Q3 2020 | 2020-09-30 | −$870,000 | $2.8M | — | −34800.00% |
| Q3 2017 | 2017-09-30 | −$3.3M | $178,648 | — | −132966.84% |
| Q4 2016 | 2016-12-31 | −$4.1M | −$133,037 | — | −46653.99% |
| Q3 2016 | 2016-09-30 | −$4.5M | $1.1M | — | −179033.04% |
| Q2 2016 | 2016-06-30 | −$3.7M | $1.2M | — | −146207.72% |
| Q1 2016 | 2016-03-31 | −$3.5M | $1.2M | — | −140112.76% |
| Q4 2015 | 2015-12-31 | −$3.9M | −$431,247 | — | −157892.84% |
| Q3 2015 | 2015-09-30 | −$5.5M | −$2.4M | — | −221615.56% |
| Q2 2015 | 2015-06-30 | −$4.9M | −$2.4M | — | −195374.20% |
| Q1 2015 | 2015-03-31 | −$4.7M | −$1.9M | — | −162354.23% |
| Q4 2014 | 2014-12-31 | −$3.5M | −$1.0M | — | −75355.21% |
| Q3 2014 | 2014-09-30 | −$3.1M | −$771,616 | — | −62570.88% |
| Q2 2014 | 2014-06-30 | −$2.4M | $917,253 | — | −48921.04% |
| Q1 2014 | 2014-03-31 | −$2.8M | −$309,527 | — | −67768.44% |
| Q4 2013 | 2013-12-31 | −$2.5M | $44,919 | — | −99294.48% |
| Q3 2013 | 2013-09-30 | −$2.4M | −$936,187 | — | −94277.12% |
| Q2 2013 | 2013-06-30 | −$3.4M | −$895,017 | — | −134532.20% |
| Q1 2013 | 2013-03-31 | −$2.5M | −$413,774 | — | −2453.06% |
| Q4 2012 | 2012-12-31 | −$2.5M | −$735,293 | — | −101091.24% |
| Q3 2012 | 2012-09-30 | −$1.4M | $398,327 | — | −831.65% |
| Q2 2012 | 2012-06-30 | −$2.5M | −$124,853 | — | −3159.41% |
| Q1 2012 | 2012-03-31 | −$2.1M | $238,007 | — | −1344.39% |
| Q4 2011 | 2011-12-31 | −$1.8M | $562,481 | — | — |
| Q3 2011 | 2011-09-30 | −$1.8M | — | — | −1758.96% |
| Q2 2011 | 2011-06-30 | −$2.3M | — | — | — |
| Q1 2011 | 2011-03-31 | −$2.3M | — | — | — |
| Q3 2010 | 2010-09-30 | −$2.4M | — | — | — |
Palisade Bio free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$7.7M to −$12.2M, a net decrease of $4.5M. Palisade Bio's latest reported quarter, Q3 2024, generated −$3.1M in free cash flow, a decrease of $2.3M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Palisade Bio filings at SEC.gov ↗